A new challenge for the Mexican health system: hepatitis C in people who inject drugs

Source:

Magís-Rodríguez, C., Marín-Navarrete, R., & García-Juárez, I. (2019). A new challenge for the Mexican health system: hepatitis C in people who inject drugs. Salud Mental, 42(4), 147-148. doi:https://doi.org/10.17711/SM.0185-3325.2019.019

Abstract

Injecting-drug use is present in 179 of 206 countries worldwide, with human immunodeficiency virus (HIV) and hepatitis C virus (HCV) prevalence of 17.8% and 52.3%, respectively, among the 15.6 million people who inject drugs (PWIDs) (Degenhardt et al., 2017; Platt et al., 2016). This epidemic produces a high impact on global public health by increasing days lost associated to disability, morbidity, and mortality (Degenhardt et al., 2017).